Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging

NCT04993508 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

1908

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST: PSA test
DEVICE: multiparametric prostate Magnetic Resonance Imaging (mpMRI)
PROCEDURE: targeted MRI/US fusion-guided biopsy
PROCEDURE: combined prostate biopsy (systematic biopsy plus targeted MRI/US fusion-guided biopsy)
PROCEDURE: MRI inbore biopsy

Sponsor

Heinrich-Heine University, Duesseldorf

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]